Ilya Goldshleger - Dec 18, 2023 Form 4 Insider Report for RxSight, Inc. (RXST)

Role
Chief Operating Officer
Signature
/s/ Shelley Thunen, as Attorney-in-Fact
Stock symbol
RXST
Transactions as of
Dec 18, 2023
Transactions value $
-$272,040
Form type
4
Date filed
12/20/2023, 06:07 PM
Previous filing
Jul 27, 2023
Next filing
Dec 26, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXST Common Stock Options Exercise $3.87K +937 +3.54% $4.13* 27.4K Dec 18, 2023 Direct
transaction RXST Common Stock Options Exercise $151K +10K +36.48% $15.08 37.4K Dec 18, 2023 Direct
transaction RXST Common Stock Sale -$36.5K -937 -2.5% $38.99 36.5K Dec 18, 2023 Direct F1, F2
transaction RXST Common Stock Sale -$191K -4.89K -13.42% $38.93 31.6K Dec 18, 2023 Direct F1, F3
transaction RXST Common Stock Sale -$4.18K -106 -0.34% $39.45 31.5K Dec 18, 2023 Direct F1
transaction RXST Common Stock Sale -$195K -5K -15.89% $39.09 26.5K Dec 18, 2023 Direct F1, F4
holding RXST Common Stock 1.37K Dec 18, 2023 By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXST Stock Option (right to buy) Options Exercise $0 -937 -4.3% $0.00 20.8K Dec 18, 2023 Common Stock 937 $4.13 Direct
transaction RXST Stock Option (right to buy) Options Exercise $0 -10K -6.89% $0.00 135K Dec 18, 2023 Common Stock 10K $15.08 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on September 13, 2023 by the Reporting Person.
F2 Represents the weighted average share price of an aggregate total of 937 shares sold in the price range of $38.45 to $39.45 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Represents the weighted average share price of an aggregate total of 4,894 shares sold in the price range of $38.41 to $39.39 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4 Represents the weighted average share price of an aggregate total of 5,000 shares sold in the price range of $39.00 to $39.45 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F5 Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2015 Equity Incentive Plan, as amended) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean April 23, 2020.